senseonics holdings inc - SENS
SENS
Close Chg Chg %
6.91 0.52 7.53%
Closed Market
7.43
+0.52 (7.53%)
Volume: 520.85K
Last Updated:
Feb 6, 2026, 4:00 PM EDT
Company Overview: senseonics holdings inc - SENS
SENS Key Data
| Open $7.01 | Day Range 6.79 - 7.55 |
| 52 Week Range 5.25 - 28.00 | Market Cap $295.41M |
| Shares Outstanding 40.86M | Public Float 36.46M |
| Beta 1.00 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$1.71 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 463.98K |
SENS Performance
| 1 Week | 1.36% | ||
| 1 Month | 2.91% | ||
| 3 Months | 23.63% | ||
| 1 Year | -64.28% | ||
| 5 Years | -87.74% |
SENS Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
8
Full Ratings ➔
About senseonics holdings inc - SENS
Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.
SENS At a Glance
Senseonics Holdings, Inc.
20451 Seneca Meadows Parkway
Germantown, Maryland 20876-7005
| Phone | 1-301-515-7260 | Revenue | 22.47M | |
| Industry | Electronic Components | Net Income | -78,616,000.00 | |
| Sector | Electronic Technology | 2024 Sales Growth | 0.366% | |
| Fiscal Year-end | 12 / 2025 | Employees | 117 | |
| View SEC Filings |
SENS Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 14.667 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -4.817 |
| Enterprise Value to Sales | 15.726 |
| Total Debt to Enterprise Value | 0.173 |
SENS Efficiency
| Revenue/Employee | 192,068.376 |
| Income Per Employee | -671,931.624 |
| Receivables Turnover | 2.782 |
| Total Asset Turnover | 0.188 |
SENS Liquidity
| Current Ratio | 2.354 |
| Quick Ratio | 2.24 |
| Cash Ratio | 1.928 |
SENS Profitability
| Gross Margin | 2.372 |
| Operating Margin | -333.046 |
| Pretax Margin | -349.84 |
| Net Margin | -349.84 |
| Return on Assets | -65.882 |
| Return on Equity | -166.29 |
| Return on Total Capital | -95.691 |
| Return on Invested Capital | -86.178 |
SENS Capital Structure
| Total Debt to Total Equity | 289.346 |
| Total Debt to Total Capital | 74.316 |
| Total Debt to Total Assets | 60.789 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | 49.282 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Senseonics Holdings Inc - SENS
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 13.68M | 16.39M | 22.39M | 22.47M | |
Sales Growth
| +176.32% | +19.85% | +36.62% | +0.37% | |
Cost of Goods Sold (COGS) incl D&A
| 14.49M | 13.66M | 19.30M | 21.94M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 1.24M | 985.00K | 1.28M | 1.48M | |
Depreciation
| 1.24M | 985.00K | 1.28M | 1.48M | |
Amortization of Intangibles
| - | - | - | - | - |
COGS Growth
| -35.08% | -5.68% | +41.25% | +13.68% | |
Gross Income
| (811.00K) | 2.73M | 3.09M | 533.00K | |
Gross Income Growth
| +95.33% | +436.13% | +13.39% | -82.76% | |
Gross Profit Margin
| -5.93% | +16.63% | +13.81% | +2.37% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 56.37M | 71.35M | 78.69M | 75.38M | |
Research & Development
| 27.22M | 39.72M | 48.75M | 41.14M | |
Other SG&A
| 29.15M | 31.63M | 29.94M | 34.23M | |
SGA Growth
| -8.73% | +26.58% | +10.29% | -4.22% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 228.64M | (227.73M) | (20.76M) | (102.00K) | |
EBIT after Unusual Expense
| (285.82M) | 159.10M | (54.85M) | (74.74M) | |
Non Operating Income/Expense
| 70.00K | 1.72M | 5.56M | 4.56M | |
Non-Operating Interest Income
| 243.00K | 1.82M | 5.36M | 4.50M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 16.72M | 18.70M | 11.11M | 8.44M | |
Interest Expense Growth
| +3.42% | +11.86% | -40.60% | -24.06% | |
Gross Interest Expense
| 16.72M | 18.70M | 11.11M | 8.44M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| (302.47M) | 142.12M | (60.39M) | (78.62M) | |
Pretax Income Growth
| -72.68% | +146.99% | -142.49% | -30.18% | |
Pretax Margin
| -2,211.88% | +867.16% | -269.73% | -349.84% | |
Income Tax
| - | - | - | - | - |
Income Tax - Current - Domestic
| - | - | - | - | - |
Income Tax - Current - Foreign
| - | - | - | - | - |
Income Tax - Deferred - Domestic
| - | - | - | - | - |
Income Tax - Deferred - Foreign
| - | - | - | - | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| (302.47M) | 142.12M | (60.39M) | (78.62M) | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| (302.47M) | 142.12M | (60.39M) | (78.62M) | |
Net Income Growth
| -72.68% | +146.99% | -142.49% | -30.18% | |
Net Margin Growth
| -2,211.88% | +867.16% | -269.73% | -349.84% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| (302.47M) | 142.12M | (60.39M) | (78.62M) | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| (302.47M) | 142.12M | (60.39M) | (78.62M) | |
EPS (Basic)
| -14.3244 | 6.074 | -2.1266 | -2.4968 | |
EPS (Basic) Growth
| +6.81% | +142.40% | -135.01% | -17.41% | |
Basic Shares Outstanding
| 21.12M | 23.40M | 28.40M | 31.49M | |
EPS (Diluted)
| -14.3244 | -2.1724 | -2.1266 | -2.4968 | |
EPS (Diluted) Growth
| +6.81% | +84.83% | +2.11% | -17.41% | |
Diluted Shares Outstanding
| 21.12M | 30.91M | 28.40M | 31.49M | |
EBITDA
| (55.94M) | (67.64M) | (74.33M) | (73.37M) | |
EBITDA Growth
| +28.27% | -20.91% | -9.88% | +1.29% | |
EBITDA Margin
| -409.09% | -412.73% | -331.96% | -326.48% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 18.917 | |
| Number of Ratings | 8 | Current Quarters Estimate | -0.563 | |
| FY Report Date | 03 / 2026 | Current Year's Estimate | -2.362 | |
| Last Quarter’s Earnings | -0.42 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | -1.463 | Next Fiscal Year Estimate | -2.053 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 8 | 8 | 8 | 7 |
| Mean Estimate | -0.56 | -0.60 | -2.36 | -2.05 |
| High Estimates | -0.36 | -0.45 | -2.00 | -1.54 |
| Low Estimate | -0.75 | -0.72 | -2.79 | -2.39 |
| Coefficient of Variance | -20.20 | -14.05 | -9.80 | -14.72 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 4 | 4 | 4 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 2 | 2 | 2 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 1 | 1 | 1 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Senseonics Holdings Inc - SENS
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Senseonics Holdings Inc - SENS
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Nov 20, 2025 | Timothy T. Goodnow President and CEO; Director | 634,018 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.26 per share | 3,968,952.68 |
| Nov 20, 2025 | Francine Ratner Kaufman Chief Medical Officer; Director | 123,948 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.26 per share | 775,914.48 |
| Nov 20, 2025 | Mukul Kumar Jain Chief Operating Officer | 259,979 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.26 per share | 1,627,468.54 |
| Nov 20, 2025 | Kenneth L. Horton GC & Corp. Development Advisor | 144,434 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.26 per share | 904,156.84 |
| Nov 20, 2025 | Frederick Sullivan Chief Financial Officer | 150,626 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.26 per share | 942,918.76 |
| Apr 4, 2025 | Douglas A. Roeder Director | 1,516,453 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $0.66 per share | 1,000,858.98 |
| Apr 4, 2025 | Edward J. Fiorentino Director | 1,204,041 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $0.66 per share | 794,667.06 |
| Apr 4, 2025 | Douglas S. Prince Director | 959,152 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $0.66 per share | 633,040.32 |
| Apr 4, 2025 | Steven V. Edelman Director | 1,124,567 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $0.66 per share | 742,214.22 |